RecruitingEarly Phase 1ACTRN12622001272785

BioSpine: multimodal rehabilitation for individuals with complete chronic spinal cord injury

BioSpine: effect of multimodal rehabilitation on symptom severity in individuals with complete chronic spinal cord injury


Sponsor

Griffith University

Enrollment

8 participants

Start Date

Apr 30, 2022

Study Type

Interventional

Conditions

Summary

Approximately 20,800 Australians are living with a spinal cord injury (SCI) and 350-400 people sustain a new spinal cord injury each year. Of these injuries ~80% are due to traumatic injury and just under half are from motor vehicle accidents. Most therapies offered for people with spinal cord injury involve passive movement of the limbs, but these approaches result in only small benefits. A robust rehabilitation alternative is available, and it includes combining the effect of multiple rehabilitation technologies. Current evidence suggests that electrical stimulation of muscle, brain-computer interfaces, virtual reality, exercise, and anti-anxiety drugs could partially restore movement and sensation in people with spinal cord injury. This research involves assessing the long-term effects of this new type of rehabilitation on motor and sensory function of people with complete spinal cord injury. We hypothesise that the proposed intervention will result in clinically measurable improvements in participants' motor and sensory function, as assessed by the American Spinal Injury Association (ASIA) impairment scale (AIS).


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 60 Yearss

Plain Language Summary

Simplified for easier understanding

Spinal cord injury can rob a person of movement and sensation below the level of injury, and for those with a complete injury (where signals from the brain cannot pass through at all), recovery has traditionally been very limited. This study is taking a bold approach: combining multiple rehabilitation technologies together — including electrical stimulation of muscles, brain-computer interfaces, virtual reality, and a carefully selected medication — in the hope that the combined effect will be greater than any single approach alone. The BioSpine program is designed for adults aged 18 to 60 who sustained a complete traumatic spinal cord injury at least two years ago. Participants will undergo an intensive multimodal rehabilitation program and be assessed using the internationally recognised ASIA impairment scale to measure any changes in movement or sensation. The study is being conducted at Griffith University and represents an early-phase investigation of this combined approach. You may be eligible if you are aged 18 to 60, have a motor-complete spinal cord injury (classified as AIS A or B) from a traumatic cause, the injury occurred at least two years ago, and you are physically able to participate in regular activity. You would not be eligible if you have severe osteoporosis, are taking certain antidepressants or antispasmodic medications, have epilepsy, have a cardiac pacemaker, or have other significant health conditions that would make participation unsafe.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Study Devices The following devices non-invasive devices will be used as part of the intervention 1. Wearable Wireless dry or wet electrode electroencephalography (EEG) headset (e.g., DSI-7, Wearabl

Study Devices The following devices non-invasive devices will be used as part of the intervention 1. Wearable Wireless dry or wet electrode electroencephalography (EEG) headset (e.g., DSI-7, Wearable Sensing, San Diego, CA, USA; All-in-One Biosensing R&D Bundle, OpenBCI, Brooklyn, NY, USA; Sessantaquattro, OT Bioelettronica, Torino (TO), Italy). This device involves non-invasively recording low voltage biosignals (i.e., electroencephalography) from the surface of a person’s scalp. This device employs electrodes that are not disturbed by hair. 2. Functional electrical stimulation (FES) uses an electric current to externally stimulate muscles to artificially create movement. Surface electrodes consisting of adhesive hypoallergenic patches are applied over the muscle groups of interest. For this intervention, pairs electrodes will be places on the muscles of the legs. The electrodes provide nothing but contact for the device and do not cause superficial or any form of damage to the skin or the skin surface. FES is non-invasive and is used in many applications such as cycling, walking, and bladder control, and it is commonly used in rehabilitation. The RT300 (Restorative Therapies, Baltimore, US) and RehaStim 2 (Hasomed, Magdeburg, Germany) devices will be used for this intervention. 3. Cycling ergometer is a stationary motorised bicycle that provide pedal assistance. For this intervention we are going to use a RT300 (Restorative Therapies, Baltimore, US), THERA-Trainer Tigo (THERA-Trainer, Hochdorf, Germany) or an equivalent device, which is wheelchair compatible and enables participants to cycle without dismounting from their wheelchair. 4. Virtual reality (VR) involves visual and/or audible simulated content often produced by a head mounted device and/or headphones. VR can offer the unique experience of being in an environment that is not possible or accessible, allowing a person to visualise an avatar in a virtual environment. VR will be used to create an engaging and stimulating cycling environment for patients and allow for a more immersive experience than presented in the laboratory. A commercially available VR headset will be used for this intervention (e.g., Oculus Rift, Facebook Technologies, LLC, Exertis, UK) or equivalent. 5. Haptic (i.e., vibration) feedback involves sensors attached to the person’s skin. As people with SCI perceive limited sensation below the level of injury, a haptic sensor will be placed above the level of injury (e.g., shoulders or base of the neck) and it will vibrate based on the amount of force applied to the pedals during cycling. The vibration is low powered and comparable to the vibration of a modern smartphone. A commercial or custom-made device will be used for this intervention. 6. Tilt table or standing frames allow moving the participant to an upright position, in a safe and controlled fashion. Positioning the participant upright contributes to reengaging the vestibular and cardiovascular system. The tilt table will primarily be used during the technology introduction stage, allowing the participant to train motor imagery using the brain-computer interface, VR and haptic feedback systems. To reduce the risk of blood pressure drop and orthostatic collapse during tilt table use, the tilt table angle will be increased incrementally, the participant will wear an abdominal binder, and the participant’s blood pressure monitored. Dosage Participants will perform at least 150 minutes per week, distributed over 2 to 3 sessions per week, of progressive neurorehabilitation for 52 weeks. One week prior commencement of therapy, participants will be administered 7.5 mg of buspirone hydrochloride in form of oral tablets, twice a day. Administration will continue throughout the intervention. To monitor adherence, at each in-person neurorehabilitation session, participants will be asked whether they have assumed the buspirone hydrochloride tables during the previous days. Additionally, participants will be requested to return unused tablets at the end of every month. Intervention An experienced exercise physiologist or physiotherapist will conduct the intervention. At the beginning of each session, the participant will be instrumented with FES electrodes on the main muscles of the lower limbs. The participant will approach the cycling ergometer in a wheelchair (a wheelchair will be provided if necessary) and secured to the pedal of the ergometer. The participant will be donned with a wireless EEG headset and VR headset. The participant will perform a passive cycling warmup on the ergometer, for a period of at least 5 minutes, to reduce the occurrence of spasticity. During the passive cycling warmup, the participant will cycle on the ergometer without electrical stimulation and with the lowest motorised torque assistance to achieve stable cycling. A calibration procedure for the brain-computer interface will be performed. This consists of 5-25 minutes wherein a virtual avatar is displayed while performing cycling movement or no movement, and the participant is asked to think about performing the visualised movement. Following calibration, the training phase will start. This involves the participant thinking about cycling. Because of this thought, the legs of the participant will be electrically stimulated to perform the desired cycling movement. The motorised cycling ergometer will also provide pedal assistance to facilitate the task. The ergometer torque will be monitored to facilitate spasm detection and response. During training the participant will also experience cycling in the VR system. Length of training session will logged to monitor participant adherence. Parameters of the FES stimulation FES stimulation electrodes will be positioned on the hamstrings, quadriceps, calves muscle groups and on the tibialis anterior, bilaterally. The electric charge of stimulation (i.e., current and pulse width) will be automatically modulated by a custom FES controller throughout the pedaling cycle in order to stimulate muscles only when mechanically advantageous. The frequency of stimulation will be set to 40Hz, and the maximum amount delivered current will not exceed 80mA.


Locations(1)

NSW,QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12622001272785